284686-20-0 Usage
Uses
1. Pharmaceutical Industry:
N-[5-BroMo-2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxaMide is used as an intermediate in the synthesis of Nevirapine metabolites for the development of antiretroviral drugs. N-[5-BroMo-2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxaMide plays a crucial role in the production process, contributing to the effectiveness of these medications in treating HIV/AIDS.
2. Chemical Research and Development:
In addition to its pharmaceutical applications, N-[5-BroMo-2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxaMide may also be utilized in chemical research and development. Its unique structure and properties make it a valuable compound for studying various chemical reactions and exploring potential applications in other fields.
Chemical Properties:
N-[5-BroMo-2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxaMide is a dark brown solid, which indicates its stability and potential for use in various chemical processes. Its specific chemical properties, such as reactivity and solubility, may be further investigated to optimize its use in different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 284686-20-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,6,8 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 284686-20:
(8*2)+(7*8)+(6*4)+(5*6)+(4*8)+(3*6)+(2*2)+(1*0)=180
180 % 10 = 0
So 284686-20-0 is a valid CAS Registry Number.
284686-20-0Relevant articles and documents
Synthesis of five nevirapine metabolites
Grozinger, Karl G.,Byrne, Denis P.,Nummy, Laurence J.,Ridges, Michael D.,Salvagno, Annette
, p. 229 - 239 (2007/10/03)
Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.
